Tiny molecules in artery plaques may reveal stroke clues
NCT ID NCT03149406
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study analyzed microRNAs in carotid artery plaques from 30 patients who had surgery to remove them. Researchers compared plaques from people who had already had a stroke (symptomatic) with those who had not (asymptomatic) to see if certain microRNAs are linked to stroke risk. The goal was to better understand why some plaques cause strokes and others do not.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new ways to predict stroke risk or develop treatments for carotid artery disease.
- What could go wrong
- This is a very small, early-stage observational study with only 30 participants. It does not test any treatment, so any potential applications are far off and uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAROTID ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new CT scanner see carotid plaques better?
- Could a green tea compound prevent second heart attacks?
- Can a cholesterol drug shrink artery plaque in diabetes patients?
- Can Omega-3 boost statins to fight artery plaque in diabetes?
- Can common heart drugs prevent artery blockage in diabetes?
- Microgreens may boost muscle recovery, tiny study hints